|Global and regional estimates of COPD prevalence: Systematic review and meta–analysis|
D Adeloye, S Chua, C Lee, C Basquill, A Papana, E Theodoratou, H Nair, ...
Journal of global health 5 (2), 2015
|Barriers to improvement of mental health services in low-income and middle-income countries|
B Saraceno, M van Ommeren, R Batniji, A Cohen, O Gureje, J Mahoney, ...
The Lancet 370 (9593), 1164-1174, 2007
|Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe|
E Han, MMJ Tan, E Turk, D Sridhar, GM Leung, K Shibuya, N Asgari, J Oh, ...
The Lancet 396 (10261), 1525-1534, 2020
|Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola|
S Moon, D Sridhar, MA Pate, AK Jha, C Clinton, S Delaunay, V Edwin, ...
The Lancet 386 (10009), 2204-2221, 2015
|SARS-CoV-2 variants and ending the COVID-19 pandemic|
A Fontanet, B Autran, B Lina, MP Kieny, SSA Karim, D Sridhar
The Lancet 397 (10278), 952-954, 2021
|Global health funding: how much, where it comes from and where it goes|
D McCoy, S Chand, D Sridhar
Health policy and planning 24 (6), 407-417, 2009
|Scientific consensus on the COVID-19 pandemic: we need to act now|
NA Alwan, RA Burgess, S Ashworth, R Beale, N Bhadelia, D Bogaert, ...
The Lancet 396 (10260), e71-e72, 2020
|Prevalence of rheumatoid arthritis in low–and middle–income countries: A systematic review and analysis|
I Rudan, S Sidhu, A Papana, SJ Meng, Y Xin–Wei, W Wang, ...
Journal of global health 5 (1), 2015
|Misfinancing global health: a case for transparency in disbursements and decision making|
D Sridhar, R Batniji
The Lancet 372 (9644), 1185-1191, 2008
|Achieving global targets for antimicrobial resistance|
R Laxminarayan, D Sridhar, M Blaser, M Wang, M Woolhouse
Science 353 (6302), 874-875, 2016
|SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties|
M Oliu-Barton, BSR Pradelski, P Aghion, P Artus, I Kickbusch, JV Lazarus, ...
The Lancet 397 (10291), 2234-2236, 2021
|Bridging the divide: global governance of trade and health|
K Lee, D Sridhar, M Patel
The Lancet 373 (9661), 416-422, 2009
|Who sets the global health research agenda? The challenge of multi-bi financing|
Public Library of Science 9 (9), e1001312, 2012
|The normative authority of the World Health Organization|
LO Gostin, D Sridhar, D Hougendobler
Public Health 129 (7), 854-863, 2015
|Governing global health: Who runs the world and why?|
C Clinton, DL Sridhar
Oxford University Press, 2017
|Global governance of antimicrobial resistance|
C Rochford, D Sridhar, N Woods, Z Saleh, L Hartenstein, H Ahlawat, ...
The Lancet 391 (10134), 1976-1978, 2018
|Trojan multilateralism: global cooperation in health|
D Sridhar, N Woods
Global Policy 4 (4), 325-335, 2013
|Government responses and COVID-19 deaths: Global evidence across multiple pandemic waves|
T Hale, N Angrist, AJ Hale, B Kira, S Majumdar, A Petherick, T Phillips, ...
PLoS One 16 (7), e0253116, 2021
|Urbanization and prevalence of type 2 diabetes in Southern Asia: A systematic analysis|
A Cheema, D Adeloye, S Sidhu, D Sridhar, KY Chan
Journal of global health 4 (1), 2014
|Post-Ebola reforms: ample analysis, inadequate action|
S Moon, J Leigh, L Woskie, F Checchi, V Dzau, M Fallah, G Fitzgerald, ...
Bmj 356, 2017